Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06029647Not ApplicableCompleted

Mangos to Reduce Cardiometabolic Risk Markers

Role: lead

NCT06006182Not ApplicableCompleted

The Effects of Freeze-Dried Whole Grape Powder on Chronic Disease and Cardiovascular Risk Factors-a Pilot Study

Role: lead

NCT04744077Not ApplicableCompleted

Physical Activity and Social-media Support

Role: lead

NCT03233906Not ApplicableUnknown

The Effects of Chia on Overweight/Obese Women

Role: lead

NCT02686905Not ApplicableUnknown

Vitamin Supplementation After Bariatric Surgery

Role: lead

NCT02849392Not ApplicableCompleted

Effects of Pistachio Consumption on Body Composition and Blood and Bone Indicators

Role: lead

All 6 trials loaded